The Effect of Prophylactic Adnexectomy on the Quality of Life and Psychosocial Functioning of Women with the BRCA1/BRCA2 Mutations

被引:6
|
作者
Stanisz, Marta [1 ]
Panczyk, Mariusz [2 ]
Kurzawa, Rafal [1 ,3 ]
Grochans, Elzbieta [4 ]
机构
[1] Pomeranian Med Univ, Dept Gynecol & Reprod Hlth, PL-71210 Szczecin, Poland
[2] Med Univ Warsaw, Dept Educ & Res Hlth Sci, PL-02091 Warsaw, Poland
[3] Ctr Gynecol & Treatmemt Infertil Vitrol, Al Wojska Polskiego 103, PL-70483 Szczecin, Poland
[4] Pomeranian Med Univ, Dept Nursing, Ul Zolnierska 48, PL-71210 Szczecin, Poland
关键词
BRCA1; BRCA2; risk-reducing salpingo-oophorectomy; quality of life; psychosocial functioning; ovarian cancer; REDUCING SALPINGO-OOPHORECTOMY; OVARIAN-CANCER; BREAST-CANCER; HEREDITARY BREAST; SEXUAL-ACTIVITY; INCREASED RISK; BRCA MUTATION; CARRIERS; IMPACT; THERAPY;
D O I
10.3390/ijerph16244995
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
The main purpose of this study was to analyze the effect of risk-reducing salpingo-oophorectomy (RRSO) on the quality of life (QoL) and psychosocial functioning of patients with the BRCA1/BRCA2 mutations. This survey-based study was conducted using the Blatt-Kupperman Index, the Women's Health Questionnaire, the Perceived Stress Scale, the State-Trait Anxiety Inventory, the Beck Depression Inventory-II, and the authors' questionnaire. All calculations were done using Statistica 13.3. The QoL after RRSO was statistically significantly lower in most domains compared with the state before surgery. The greatest decline in the QoL was observed in the vasomotor symptoms domain (d = 0.953) and the smallest in the memory/concentration domain (d = 0.167). We observed a statistically significant decrease in the level of anxiety as a state (d = 0.381), as well as a statistically significant increase in the severity of climacteric symptoms (d = 0.315) and depressive symptoms (d = 0.125). Prophylactic surgeries of the reproductive organs have a negative effect on the QoL and psychosocial functioning of women with the BRCA1/2 mutations, as they increase the severity of depressive and climacteric symptoms. At the same time, these surgeries reduce anxiety as a state, which may be associated with the elimination of cancerophobia.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Prophylactic oophorectomy may differentially reduce breast cancer risk in women with BRCA1 versus BRCA2 mutations
    Angela G. Arnold
    Noah D. Kauff
    Current Breast Cancer Reports, 2009, 1 (3) : 157 - 161
  • [22] Family History of Cancer and Cancer Risks in Women with BRCA1 or BRCA2 Mutations
    Metcalfe, Kelly
    Lubinski, Jan
    Lynch, Henry T.
    Ghadirian, Parviz
    Foulkes, William D.
    Kim-Sing, Charmaine
    Neuhausen, Susan
    Tung, Nadine
    Rosen, Barry
    Gronwald, Jacek
    Ainsworth, Peter
    Sweet, Kevin
    Eisen, Andrea
    Sun, Ping
    Narod, Steven A.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (24): : 1874 - 1878
  • [23] Breast cancer risk for Korean women with germline mutations in BRCA1 and BRCA2
    Park, Boyoung
    Dowty, James G.
    Ahn, Choonghyun
    Win, Aung K.
    Kim, Sung-Won
    Lee, Min Hyuk
    Lee, Jong Won
    Kang, Eunyoung
    Hopper, John L.
    Park, Sue K.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 152 (03) : 659 - 665
  • [24] Validity of models for predicting BRCA1 and BRCA2 mutations
    Parmigiani, Giovanni
    Chen, Sining
    Iversen, Edwin S., Jr.
    Friebel, Tara M.
    Finkelstein, Dianne M.
    Anton-Culver, Hoda
    Ziogas, Argyrios
    Weber, Barbara L.
    Eisen, Andrea
    Malone, Kathleen E.
    Daling, Janet R.
    Hsu, Li
    Ostrander, Elaine A.
    Peterson, Leif E.
    Schildkraut, Joellen M.
    Isaacs, Claudine
    Corio, Camille
    Leondaridis, Leoni
    Tomlinson, Gail
    Amos, Christopher I.
    Strong, Louise C.
    Berry, Donald A.
    Weitzel, Jeffrey N.
    Sand, Sharon
    Dutson, Debra
    Kerber, Rich
    Peshkin, Beth N.
    Euhus, David M.
    ANNALS OF INTERNAL MEDICINE, 2007, 147 (07) : 441 - 450
  • [25] The role of BRCA1 and BRCA2 mutations in prostate, pancreatic and stomach cancers
    Cavanagh, Helen
    Rogers, Katherine M. A.
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2015, 13
  • [26] Clinical implications of genetic testing for BRCA1 and BRCA2 mutations in Austria
    Singer, C. F.
    Muhr, D.
    Rappaport, C.
    Tea, M-K
    Gschwantler-Kaulich, D.
    Fink-Retter, A.
    Pfeiler, G.
    Berger, A.
    Sun, P.
    Narod, S. A.
    CLINICAL GENETICS, 2014, 85 (01) : 72 - 75
  • [27] The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: An international prospective cohort study
    Segev, Yakir
    Iqbal, Javaid
    Lubinski, Jan
    Gronwald, Jacek
    Lynch, Henry T.
    Moller, Pal
    Ghadirian, Parviz
    Rosen, Barry
    Tung, Nadine
    Kim-Sing, Charmaine
    Foulkes, William D.
    Neuhausen, Susan L.
    Senter, Leigha
    Singer, Christian F.
    Karlan, Beth
    Ping, Sun
    Narod, Steven A.
    GYNECOLOGIC ONCOLOGY, 2013, 130 (01) : 127 - 131
  • [28] Clinical characteristics and outcomes in elderly women with BRCA1 and BRCA2 mutations
    Salyer, Chelsea
    Kobelka, Christine
    Barrie, Allison
    Weintraub, Miranda Ritterman
    Powell, C. Bethan
    GYNECOLOGIC ONCOLOGY, 2019, 154 (02) : 374 - 378
  • [29] BRCA1 and BRCA2 Mutations and Breast Cancer
    Narod, Steven A.
    Salmena, Leonardo
    DISCOVERY MEDICINE, 2011, 12 (66) : 445 - 453
  • [30] Management Updates for Women with a BRCA1 or BRCA2 Mutation
    Rachel Nusbaum
    Claudine Isaacs
    Molecular Diagnosis & Therapy, 2007, 11 : 133 - 144